Milestone Pharmaceuticals

formerly Milestone Pharmaceuticals Inc. Common SharesIPO

With You Every Beat of the Way

Public · Montreal, Canada · Founded 2003 · $180.0M raised

Headquarters
Montreal
Employees
11–50
Founded
2003
Business Model
B2C
Total Funding
$180.0M
Last Round
$125.0M Growth EquityMar 2023
Rounds
4
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Milestone Pharmaceuticals is a patient-centric, commercial-stage biopharmaceutical company whose product is FDA approved for the conversion of acute symptomatic episodes of PSVT to sinus rhythm in adults. The company also continues clinical investigation of etripamil as a treatment for atrial fibrillation with rapid ventricular rate (AFib-RVR). Since its founding, Milestone has focused on developing treatment solutions that can be self-administered when needed, minimizing overhead and directing spending toward therapies that fill unmet needs for people living with episodic cardiovascular conditions and their families.

Summary

Milestone Pharmaceuticals is a Biotech company based in Montreal, Canada, founded in 2003. It has raised $180.0M in total across 4 rounds, most recently a $125.0M Growth Equity round in Mar 2023. Investors include RTW Investments, Novo Holdings A/S and Forbion Capital Partners.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOJul 2025
$48.7M

Sign up to see all 5 events

Funding: Series B through Growth Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Milestone Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/milestone-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/milestone-pharmaceuticals" alt="Milestone Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>